为患有生化复发和晚期前列腺癌的男性实施基于证据的策略:美国前列腺癌会议2024年的共识建议
Alan H Bryce1, Neeraj Agarwal2, Himisha Beltran3
1Department of Medical Oncology and Therapeutics Research, City of Hope Phoenix, Phoenix, Arizona, USA.
Cancer
|December 1, 2024
概括
2024年美国前列腺癌会议 (USPCC 2024) 制定了34项前列腺癌管理的共识建议,解决了超出当前高水平证据的临床问题. 这些指南帮助临床医生实施新的治疗方法和技术,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 临床实践指南 临床实践指南
背景情况:
- 目前美国针对晚期前列腺癌的临床实践指南缺乏针对未被前性试验所涵盖的细微,基于实践的临床问题的指导.
- 需要专家驱动的建议来弥补每日前列腺癌管理中的证据差距.
研究的目的:
- 为缺乏1级证据的晚期前列腺癌管理提供以美国为中心的专家临床决策指导.
- 解决日常实践中遇到的实际临床挑战.
主要方法:
- 2024年美国前列腺癌会议 (USPCC 2024) 召开了一个多学科专家小组.
- 经过修改的Delphi流程,讨论了5个关键主题领域,并制定了共识建议.
主要成果:
- 由USPCC 2024专家制定了34项共识建议.
- 建议涵盖生化复发,转移性割敏感前列腺癌,PARP抑制剂,PSMA放射性对象疗法和转移性割抵抗性前列腺癌.
- 指导侧重于新型治疗和技术的实施.
结论:
- 2024年USPCC为临床医生管理晚期前列腺癌提供了宝贵的指导,特别是在具有有限高水平证据的领域.
- 该报告强调了专家共识的领域,并确定了当前临床证据的翻译应用中的未满足需求.
更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.8K
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.5K
相关概念视频
Disorders of the Male Reproductive System
331
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
331
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
